NSE filing, NSE: BIOPOL. Summary written from the filing by ALFA Finder's alert engine.
Biopol Chemicals Ltd: key numbers
- Share price
- ₹44.55
- Market cap
- ₹48.14 Cr
- Revenue (annual)
- ₹81.14 Cr
- Net profit (annual)
- ₹8.97 Cr
- P/E (TTM)
- 5.4×Sector 34.1×
- Promoter holding
- 65.81%+0.00% QoQ
- FII holding
- 0.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Biopol Chemicals Ltd
All →Biopol Chemicals Other Announcement
Biopol Chemicals Limited has intimated the exchange regarding the non-applicability of the Corporate Governance Report for the quarter ended September 30, 2026.
Biopol Chemicals Management Change
Biopol Chemicals Limited regularised the appointment of Mr. Sukhomoy Das as an Independent Director for a five-year term, effective June 11, 2026, following shareholder approval.
Biopol Chemicals Annual General Meeting
Biopol Chemicals Limited held its 3rd Annual General Meeting on September 22, 2026, via video conferencing. The meeting transacted ordinary and special business items.
Biopol Chemicals Business Update
Biopol Chemicals Limited participated in the 53rd Dye+Chem Bangladesh 2026 International Expo held in Dhaka from September 2 to September 5, 2026.
Biopol Chemicals Price Movement Clarification
Biopol Chemicals Limited clarified that recent share price movements are entirely market-driven. The company confirmed it has no undisclosed material information affecting trading volume or price.
Biopol Chemicals Annual General Meeting
Biopol Chemicals Limited issued notice for its 3rd Annual General Meeting on September 22, 2026 via video conferencing. The agenda includes financial adoption and director appointments.
Other board meeting date announcements
All →Mehta Securities Board Meeting Date
Mehta Securities has scheduled a board meeting on 6 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed from 1 October 2026 until 48 hours after results.
Mehta Integrated Finance Board Meeting Date
Mehta Integrated Finance scheduled a board meeting on November 6, 2026 to approve half-year results. The trading window remains closed until results are declared.
Sanjivani Paranteral Board Meeting Date
Sanjivani Paranteral will hold a board meeting on 5 November 2026 to approve Q2 unaudited results. The agenda is only proposed until the meeting is held.
Kalpataru Projects International Board Meeting Date
Kalpataru Projects will hold a board meeting on November 5, 2026 to approve quarterly and half-year results. An investor call follows on November 6, and the trading window stays closed.
NACDAC Infrastructure Board Meeting Date
NACDAC Infrastructure will hold a board meeting on November 4, 2026 to approve unaudited standalone half-year results ended September 30, 2026. Trading window remains closed until 48 hours after declaration.
Deep Health AI India Board Meeting Date
Deep Health AI will hold a board meeting on 3 November 2026 for unaudited quarterly and half-year results. Trading window stays closed until 48 hours after results.